Clinical Focus ›› 2022, Vol. 37 ›› Issue (6): 568-571.doi: 10.3969/j.issn.1004-583X.2022.06.018
Previous Articles Next Articles
-
Received:2022-05-23Online:2022-06-20Published:2022-08-05
CLC Number:
Cite this article
share this article
Add to citation manager EndNote|Ris|BibTeX
URL: https://huicui.hebmu.edu.cn/EN/10.3969/j.issn.1004-583X.2022.06.018
| [1] |
Giuseppe P, Giuseppe P, Andrea N, et al. Diabetic kidney disease: New clinical and therapeutic issues. Joint position statement of the Italian Diabetes Society and the Italian Society of Nephrology on “The natural history of diabetic kidney disease and treatment of hyperglycemia in patients with type 2 diabetes and impaired renal function”[J]. J Nephrol, 2020, 33(1):9-35.
doi: 10.1007/s40620-019-00650-x pmid: 31576500 |
| [2] |
Alicic RZ, Rooney MT, Tuttle KR. Diabetic kidney disease: Challenges, progress, and possibilities[J]. Clin J Am Soc Nephrol, 2017, 12(12):2032-2045.
doi: 10.2215/CJN.11491116 URL |
| [3] | Ritz E, Zeng XX, Rychlík I. Clinical manifestation and natural history of diabetic nephropathy[J]. Contrib Nephrol, 2011, 170:19-27. |
| [4] |
Chaykovska L, Heunisch F, von Einem G, et al. Urinary vitamin d binding protein and KIM-1 are potent new biomarkers of major adverse renal events in patients undergoing coronary angiography[J]. PLoS One, 2016, 11(1):e0145723.
doi: 10.1371/journal.pone.0145723 URL |
| [5] |
Shoukry A, Bdeer Sel-A, El-Sokkary RH, et al. Urinary monocyte chemoattractant protein-1 and vitamin D-binding protein as biomarkers for early detection of diabetic nephropathy in type 2 diabetes mellitus[J]. Mol Cell Biochem, 2015, 408(1-2):25-35.
doi: 10.1007/s11010-015-2479-y pmid: 26104579 |
| [6] | Turkes GF, Uysal S, Demir T, et al. Associations between bioavailable vitamin d and remnant cholesterol in patients with type 2 diabetes mellitus[J]. Cureus, 2021, 13(2):e13248. |
| [7] |
Rozmus D, Płomiński J, Augustyn K, et al. rs7041 and rs4588 polymorphisms in vitamin D binding protein gene (VDBP) and the risk of diseases[J]. Int J Mol Sci, 2022, 23(2):933.
doi: 10.3390/ijms23020933 URL |
| [8] |
Eisa NH, Khodir AE, El-Sherbiny M, et al. Phenethyl isothiocyanate attenuates diabetic nephropathy via modulation of glycative/oxidative/inflammatory signaling in diabetic rats[J]. Biomed Pharmacother, 2021, 142:111666.
doi: 10.1016/j.biopha.2021.111666 URL |
| [9] |
Fu Y, Sun Y, Wang M, et al. Elevation of JAML promotes diabetic kidney disease by modulating podocyte lipid metabolism[J]. Cell Metab, 2020, 32(6):1052-1062.
doi: 10.1016/j.cmet.2020.10.019 URL |
| [10] |
Yoshibayashi M, Kume S, Yasuda-Yamahara M, et al. Protective role of podocyte autophagy against glomerular endothelial dysfunction in diabetes[J]. Biochem Biophys Res Commun, 2020, 525(2):319-325.
doi: 10.1016/j.bbrc.2020.02.088 URL |
| [11] | Fawzy MS, Beladi FIA. Association of circulating vitamin D, VDBP, and vitamin D receptor expression with severity of diabetic nephropathy in a group of saudi type 2 diabetes mellitus patients[J]. Clin Lab, 2018, 64(10):1623-1633. |
| [12] |
Lowe G, Woodward M, Hillis G, et al. Circulating inflammatory markers and the risk of vascular complications and mortality in people with type 2 diabetes and cardiovascular disease or risk factors: The ADVANCE Study[J]. Diabetes, 2014, 63(3):1115-23.
doi: 10.2337/db12-1625 URL |
| [13] |
María-Castro A, Concha MDL, Pantoja-Meléndez CA. Low-grade inflammation and its relation to obesity and chronic degenerative diseases[J]. Revista Médica Del Hospital General De México, 2016, 80(2):101-105.
doi: 10.1016/j.hgmx.2016.06.011 URL |
| [14] | Fawzy MS, Beladi FIA. Association of circulating vitamin D, VDBP, and vitamin D receptor expression with severity of diabetic nephropathy in a group of saudi type 2 diabetes mellitus patients[J]. Clin Lab, 2018, 64(10):1623-1633. |
| [15] |
Bai X, Luo Q, Tan K, et al. Diagnostic value of VDBP and miR-155-5p in diabetic nephropathy and the correlation with urinary microalbumin[J]. Exp Ther Med, 2020, 20(5):86.
doi: 10.3892/etm.2020.9214 pmid: 32968443 |
| [16] | Fawzy MS, Beladi FIA. Association of circulating vitamin D, VDBP, and vitamin D receptor expression with severity of diabetic nephropathy in a group of saudi type 2 diabetes mellitus patients[J]. Clin Lab, 2018, 64(10):1623-1633. |
| [17] | Fawzy MS, Abu AlSel BT. Assessment of vitamin D-binding protein and early prediction of nephropathy in type 2 saudi diabetic patients[J]. J Diabetes Res, 2018, 8517929. |
| [18] | Hirai M, Suzuki S, Hinokio Y, et al. Variations in vitamin D-binding protein (group-specific component protein) are associated with fasting plasma insulin levels in Japanese with normal glucose tolerance[J]. J Clin Endocrinol Metab, 2000, 85(5):1951-1953. |
| [19] |
Lunyera J, Davenport CA, Pendergast J, et al. Modifiers of plasma 25-hydroxyvitamin d and chronic kidney disease outcomes in black americans: The jackson heart study[J]. J Clin Endocrinol Metab, 2019, 104(6):2267-2276.
doi: 10.1210/jc.2018-01747 pmid: 30668751 |
| [20] |
Corica D, Zusi C, Olivieri F, et al. Vitamin D affects insulin sensitivity and β-cell function in obese non-diabetic youths[J]. Eur J Endocrinol, 2019, 181(4):439-450.
doi: 10.1530/EJE-19-0369 URL |
| [21] | Al Ghadeer HA, AlRamadan MS, Al Amer MM, et al. Vitamin D serum levels in type 2 diabetic patients: A cross-sectional study[J]. Cureus, 2022, 14(2):e22558. |
| [22] |
Ashraf AP, Huisingh C, Alvarez JA, et al. Insulin resistance indices are inversely associated with vitamin D binding protein concentrations[J]. J Clin Endocrinol Metab, 2014, 99(1):178-183.
doi: 10.1210/jc.2013-2452 URL |
| [23] |
Li C, Su F, Liang Z, et al. Macrophage M1 regulatory diabetic nephropathy is mediated by m6A methylation modification of lncRNA expression[J]. Mol Immunol, 2022, 144:16-25.
doi: 10.1016/j.molimm.2022.02.008 URL |
| [24] | Cantero-Navarro E, Rayego-Mateos S, Orejudo M, et al. Role of macrophages and related cytokines in kidney disease[J]. Front Med (Lausanne), 2021, 8:688060. |
| [25] | Nishikawa T, Edelstein D, Brownlee M. The missing link: A single unifying mechanism for diabetic complications[J]. Kidney Int Suppl, 2000, 77:S26-S30. |
| [26] |
Jiang WJ, Xu CT, Du CL, et al. Tubular epithelial cell-to-macrophage communication forms anegative feedback loop via extracellular vesicle transfer to promote renal inflammation and apoptosis in diabetic nephropathy[J]. Theranostics, 2022, 12(1):324-339.
doi: 10.7150/thno.63735 URL |
| [27] |
Ma L, Wu F, Shao Q, et al. Baicalin alleviates oxidative stress and inflammation in diabetic nephropathy via Nrf2 and MAPK signaling pathway[J]. Drug Des Devel Ther, 2021, 15:3207-3221.
doi: 10.2147/DDDT.S319260 URL |
| [28] | Fawzy MS, Abu AlSel BT. Assessment of vitamin D-binding protein and early prediction of nephropathy in type 2 saudi diabetic patients[J]. J Diabetes Res, 2018: 8517929. |
| [29] | Fowlkes JL, Bunn RC, Cockrell GE, et al. Dysregulation of the intrarenal vitamin D endocytic pathway in a nephropathy-prone mouse model of type 1 diabetes[J]. Exp Diabetes Res, 2011, 269378. |
| [30] | Gharib AF, Askary AE, Almehmadi M, et al. Vitamin D and hypoxia-inducible factor (HIF-1α) serum levels as markers for progression of nephropathy in type 2 diabetic patients[J]. Clin Lab, 2022, 68(4):10.7754. |
| [31] | Pastukhova Y, Luzza F, Shevel S, et al. Changes in metabolic parameters in patients with diabetic kidney disease depending on the status of D3[J]. Rev Recent Clin Trials, 2022. |
| [32] |
Shi L, Xiao C, Zhang Y, et al. Vitamin D/vitamin D receptor/Atg16L1 axis maintains podocyte autophagy and survival in diabetic kidney disease[J]. Ren Fail, 2022, 44(1):694-705.
doi: 10.1080/0886022X.2022.2063744 URL |
| [1] | . [J]. Clinical Focus, 2023, 38(11): 1042-1047. |
| [2] | Wang Pin, Zhang Jing. Clinical significance of serum high mobility group protein B1 and serum amyloid aprotein levels in newborn with septic shock [J]. Clinical Focus, 2021, 36(6): 545-547. |
| [3] | . [J]. CLINICAL FOCUS, 2011, 26(2): 170-172. |
| [4] | . [J]. CLINICAL FOCUS, 2004, 19(24): 1419-1421. |
| Viewed | ||||||
|
Full text |
|
|||||
|
Abstract |
|
|||||